Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.
about
Novel and unique diagnostic biomarkers for Bacillus anthracis infection.Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidatesYersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague.Chimeric flagellin expressed by Salmonella typhimurium induces an ESAT-6-specific Th1-type immune response and CTL effects following intranasal immunizationAntigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines.Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaquesFlagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis.Search for Bacillus anthracis potential vaccine candidates by a functional genomic-serologic screen.Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.Pathogen-specific recombinant human polyclonal antibodies: biodefence applications.Identification of in vivo-expressed immunogenic proteins by serological proteome analysis of the Bacillus anthracis secretome.Development of an improved selective agar medium for isolation of Yersinia pestis.Protection against pneumonic plague following oral immunization with a non-replicating vaccine.A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plagueAn IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plagueProgress in the development of genetic immunization.Protective immunity against lethal F. tularensis holarctica LVS provided by vaccination with selected novel CD8+ T cell epitopes.Prospects for new plague vaccines.Live-attenuated Yersinia pestis vaccines.Plague Vaccines: Status and Future.The solute-binding component of a putative Mn(II) ABC transporter (MntA) is a novel Bacillus anthracis virulence determinant.Discordance in the effects of Yersinia pestis on the dendritic cell functions manifested by induction of maturation and paralysis of migration.Sequential proteolytic processing of the capsular Caf1 antigen of Yersinia pestis for major histocompatibility complex class II-restricted presentation to T lymphocytes.
P2860
Q30157179-A155BA25-9EA3-430B-B6EC-39CDEDE8CBF1Q31037921-F6D2DCC3-F799-4CBB-9FB5-427AF2CC915BQ33468419-27795BA5-61CE-4CE0-B6D2-C444F08008C4Q33577674-954323B3-786B-418C-9D47-C64C41640BCEQ33698142-B446A9FB-A694-4BA7-8079-A69E0E4EB25BQ34290878-21A86A96-4A89-462C-8400-CBCDD3729020Q34334406-9ADCC9D4-9D0C-4D6D-A127-A42923E4399AQ34681023-04AE08D6-B6CE-48C3-BFAF-B1C558AD43ADQ34721071-52197DE7-D25B-4BC9-B4C7-2560ECC912C8Q34819434-E16C3C83-A857-484D-875A-E53A9904A076Q35684876-FF459732-5EFE-40A6-BA7E-225258FA1161Q35913411-989E0B52-9B7D-4EA9-80BF-5C88CAAC1BDCQ36049051-2EF2E346-F188-4E0A-9E93-8167F25423BDQ36099515-2DDD194F-C45C-4502-9CE1-3DEF3F38DDBAQ36898462-242FFA2F-8A13-45D7-A44E-B3DCE1C8042FQ37066749-473F4FB9-ECB8-4956-ABE2-1676B5658CBFQ37316018-6D9E6C19-7807-4465-97BD-C369D573915EQ37439350-12C5133D-DE5D-4988-92F1-9167AE3FD6A6Q37640118-E534B14E-D001-46DD-BEEE-4DCA64D5D307Q38113270-18566780-081C-4A88-B5AD-2FB070240E04Q38813137-2AE40D9D-7CA2-427C-9C40-37E716E57393Q40384956-90FDEC87-29D8-449F-9B57-C89D50C93768Q40953110-558380AA-F947-4CF0-A9CE-C515E3734F89Q41453072-E29F88E5-7A05-4DC2-8F0E-369DD259B09C
P2860
Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Effective protective immunity ...... es of the F1 capsular antigen.
@ast
Effective protective immunity ...... es of the F1 capsular antigen.
@en
Effective protective immunity ...... es of the F1 capsular antigen.
@nl
type
label
Effective protective immunity ...... es of the F1 capsular antigen.
@ast
Effective protective immunity ...... es of the F1 capsular antigen.
@en
Effective protective immunity ...... es of the F1 capsular antigen.
@nl
prefLabel
Effective protective immunity ...... es of the F1 capsular antigen.
@ast
Effective protective immunity ...... es of the F1 capsular antigen.
@en
Effective protective immunity ...... es of the F1 capsular antigen.
@nl
P2093
P2860
P1476
Effective protective immunity ...... es of the F1 capsular antigen.
@en
P2093
Avigdor Shafferman
Baruch Velan
Chanoch Kronman
Emanuelle Mamroud
Haim Grosfeld
Raphael Ber
Sara Cohen
Tamar Bino
Yehuda Flashner
P2860
P304
P356
10.1128/IAI.71.1.374-383.2003
P407
P577
2003-01-01T00:00:00Z